Pharma & Healthcare
Global Pomalidomide Capsules Market Research Report 2024
- Sep 18, 24
- ID: 553592
- Pages: 80
- Figures: 85
- Views: 1
Pomalidomide capsules are an oral medication used to treat multiple myeloma. Pomalidomide is an immunomodulatory agent that works by modifying the immune system, inhibiting the growth of these cells, and disrupting their ability to form new blood vessels.
The global Pomalidomide Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pomalidomide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pomalidomide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pomalidomide Capsules include Bristol Myers Squibb, Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical, Apotex, Dr Reddy’s Laboratories, Natco Pharma, Adalvo, Hetero, Abbott Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pomalidomide Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pomalidomide Capsules.
The Pomalidomide Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pomalidomide Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pomalidomide Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol Myers Squibb
Chia Tai Tianqing Pharmaceutical
Qilu Pharmaceutical
Apotex
Dr Reddy’s Laboratories
Natco Pharma
Adalvo
Hetero
Abbott Laboratories
Segment by Type
1mg per Unit
2mg per Unit
3mg per Unit
4mg per Unit
Segment by Application
Kaposi Sarcoma
Multiple Myeloma
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pomalidomide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pomalidomide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pomalidomide Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pomalidomide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pomalidomide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pomalidomide Capsules include Bristol Myers Squibb, Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical, Apotex, Dr Reddy’s Laboratories, Natco Pharma, Adalvo, Hetero, Abbott Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pomalidomide Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pomalidomide Capsules.
The Pomalidomide Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pomalidomide Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pomalidomide Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol Myers Squibb
Chia Tai Tianqing Pharmaceutical
Qilu Pharmaceutical
Apotex
Dr Reddy’s Laboratories
Natco Pharma
Adalvo
Hetero
Abbott Laboratories
Segment by Type
1mg per Unit
2mg per Unit
3mg per Unit
4mg per Unit
Segment by Application
Kaposi Sarcoma
Multiple Myeloma
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pomalidomide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pomalidomide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pomalidomide Capsules Market Overview
1.1 Product Definition
1.2 Pomalidomide Capsules by Type
1.2.1 Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030)
1.2.2 1mg per Unit
1.2.3 2mg per Unit
1.2.4 3mg per Unit
1.2.5 4mg per Unit
1.3 Pomalidomide Capsules by Application
1.3.1 Global Pomalidomide Capsules Market Value by Application (2024-2030)
1.3.2 Kaposi Sarcoma
1.3.3 Multiple Myeloma
1.4 Global Pomalidomide Capsules Market Size Estimates and Forecasts
1.4.1 Global Pomalidomide Capsules Revenue 2019-2030
1.4.2 Global Pomalidomide Capsules Sales 2019-2030
1.4.3 Global Pomalidomide Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pomalidomide Capsules Market Competition by Manufacturers
2.1 Global Pomalidomide Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pomalidomide Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pomalidomide Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pomalidomide Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pomalidomide Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pomalidomide Capsules, Product Type & Application
2.7 Global Key Manufacturers of Pomalidomide Capsules, Date of Enter into This Industry
2.8 Global Pomalidomide Capsules Market Competitive Situation and Trends
2.8.1 Global Pomalidomide Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pomalidomide Capsules Players Market Share by Revenue
2.8.3 Global Pomalidomide Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pomalidomide Capsules Market Scenario by Region
3.1 Global Pomalidomide Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pomalidomide Capsules Sales by Region: 2019-2030
3.2.1 Global Pomalidomide Capsules Sales by Region: 2019-2024
3.2.2 Global Pomalidomide Capsules Sales by Region: 2025-2030
3.3 Global Pomalidomide Capsules Revenue by Region: 2019-2030
3.3.1 Global Pomalidomide Capsules Revenue by Region: 2019-2024
3.3.2 Global Pomalidomide Capsules Revenue by Region: 2025-2030
3.4 North America Pomalidomide Capsules Market Facts & Figures by Country
3.4.1 North America Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pomalidomide Capsules Sales by Country (2019-2030)
3.4.3 North America Pomalidomide Capsules Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pomalidomide Capsules Market Facts & Figures by Country
3.5.1 Europe Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pomalidomide Capsules Sales by Country (2019-2030)
3.5.3 Europe Pomalidomide Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pomalidomide Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Pomalidomide Capsules Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pomalidomide Capsules Sales by Region (2019-2030)
3.6.3 Asia Pacific Pomalidomide Capsules Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pomalidomide Capsules Market Facts & Figures by Country
3.7.1 Latin America Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pomalidomide Capsules Sales by Country (2019-2030)
3.7.3 Latin America Pomalidomide Capsules Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pomalidomide Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pomalidomide Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pomalidomide Capsules Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pomalidomide Capsules Sales by Type (2019-2030)
4.1.1 Global Pomalidomide Capsules Sales by Type (2019-2024)
4.1.2 Global Pomalidomide Capsules Sales by Type (2025-2030)
4.1.3 Global Pomalidomide Capsules Sales Market Share by Type (2019-2030)
4.2 Global Pomalidomide Capsules Revenue by Type (2019-2030)
4.2.1 Global Pomalidomide Capsules Revenue by Type (2019-2024)
4.2.2 Global Pomalidomide Capsules Revenue by Type (2025-2030)
4.2.3 Global Pomalidomide Capsules Revenue Market Share by Type (2019-2030)
4.3 Global Pomalidomide Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pomalidomide Capsules Sales by Application (2019-2030)
5.1.1 Global Pomalidomide Capsules Sales by Application (2019-2024)
5.1.2 Global Pomalidomide Capsules Sales by Application (2025-2030)
5.1.3 Global Pomalidomide Capsules Sales Market Share by Application (2019-2030)
5.2 Global Pomalidomide Capsules Revenue by Application (2019-2030)
5.2.1 Global Pomalidomide Capsules Revenue by Application (2019-2024)
5.2.2 Global Pomalidomide Capsules Revenue by Application (2025-2030)
5.2.3 Global Pomalidomide Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Pomalidomide Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb Pomalidomide Capsules Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Chia Tai Tianqing Pharmaceutical
6.2.1 Chia Tai Tianqing Pharmaceutical Company Information
6.2.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.2.3 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product Portfolio
6.2.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.3 Qilu Pharmaceutical
6.3.1 Qilu Pharmaceutical Company Information
6.3.2 Qilu Pharmaceutical Description and Business Overview
6.3.3 Qilu Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Qilu Pharmaceutical Pomalidomide Capsules Product Portfolio
6.3.5 Qilu Pharmaceutical Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Pomalidomide Capsules Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Dr Reddy’s Laboratories
6.5.1 Dr Reddy’s Laboratories Company Information
6.5.2 Dr Reddy’s Laboratories Description and Business Overview
6.5.3 Dr Reddy’s Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dr Reddy’s Laboratories Pomalidomide Capsules Product Portfolio
6.5.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.6 Natco Pharma
6.6.1 Natco Pharma Company Information
6.6.2 Natco Pharma Description and Business Overview
6.6.3 Natco Pharma Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Natco Pharma Pomalidomide Capsules Product Portfolio
6.6.5 Natco Pharma Recent Developments/Updates
6.7 Adalvo
6.7.1 Adalvo Company Information
6.7.2 Adalvo Description and Business Overview
6.7.3 Adalvo Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Adalvo Pomalidomide Capsules Product Portfolio
6.7.5 Adalvo Recent Developments/Updates
6.8 Hetero
6.8.1 Hetero Company Information
6.8.2 Hetero Description and Business Overview
6.8.3 Hetero Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hetero Pomalidomide Capsules Product Portfolio
6.8.5 Hetero Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Company Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abbott Laboratories Pomalidomide Capsules Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pomalidomide Capsules Industry Chain Analysis
7.2 Pomalidomide Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pomalidomide Capsules Production Mode & Process
7.4 Pomalidomide Capsules Sales and Marketing
7.4.1 Pomalidomide Capsules Sales Channels
7.4.2 Pomalidomide Capsules Distributors
7.5 Pomalidomide Capsules Customers
8 Pomalidomide Capsules Market Dynamics
8.1 Pomalidomide Capsules Industry Trends
8.2 Pomalidomide Capsules Market Drivers
8.3 Pomalidomide Capsules Market Challenges
8.4 Pomalidomide Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pomalidomide Capsules by Type
1.2.1 Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030)
1.2.2 1mg per Unit
1.2.3 2mg per Unit
1.2.4 3mg per Unit
1.2.5 4mg per Unit
1.3 Pomalidomide Capsules by Application
1.3.1 Global Pomalidomide Capsules Market Value by Application (2024-2030)
1.3.2 Kaposi Sarcoma
1.3.3 Multiple Myeloma
1.4 Global Pomalidomide Capsules Market Size Estimates and Forecasts
1.4.1 Global Pomalidomide Capsules Revenue 2019-2030
1.4.2 Global Pomalidomide Capsules Sales 2019-2030
1.4.3 Global Pomalidomide Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pomalidomide Capsules Market Competition by Manufacturers
2.1 Global Pomalidomide Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pomalidomide Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pomalidomide Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pomalidomide Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pomalidomide Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pomalidomide Capsules, Product Type & Application
2.7 Global Key Manufacturers of Pomalidomide Capsules, Date of Enter into This Industry
2.8 Global Pomalidomide Capsules Market Competitive Situation and Trends
2.8.1 Global Pomalidomide Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pomalidomide Capsules Players Market Share by Revenue
2.8.3 Global Pomalidomide Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pomalidomide Capsules Market Scenario by Region
3.1 Global Pomalidomide Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pomalidomide Capsules Sales by Region: 2019-2030
3.2.1 Global Pomalidomide Capsules Sales by Region: 2019-2024
3.2.2 Global Pomalidomide Capsules Sales by Region: 2025-2030
3.3 Global Pomalidomide Capsules Revenue by Region: 2019-2030
3.3.1 Global Pomalidomide Capsules Revenue by Region: 2019-2024
3.3.2 Global Pomalidomide Capsules Revenue by Region: 2025-2030
3.4 North America Pomalidomide Capsules Market Facts & Figures by Country
3.4.1 North America Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pomalidomide Capsules Sales by Country (2019-2030)
3.4.3 North America Pomalidomide Capsules Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pomalidomide Capsules Market Facts & Figures by Country
3.5.1 Europe Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pomalidomide Capsules Sales by Country (2019-2030)
3.5.3 Europe Pomalidomide Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pomalidomide Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Pomalidomide Capsules Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pomalidomide Capsules Sales by Region (2019-2030)
3.6.3 Asia Pacific Pomalidomide Capsules Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pomalidomide Capsules Market Facts & Figures by Country
3.7.1 Latin America Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pomalidomide Capsules Sales by Country (2019-2030)
3.7.3 Latin America Pomalidomide Capsules Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pomalidomide Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pomalidomide Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pomalidomide Capsules Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pomalidomide Capsules Sales by Type (2019-2030)
4.1.1 Global Pomalidomide Capsules Sales by Type (2019-2024)
4.1.2 Global Pomalidomide Capsules Sales by Type (2025-2030)
4.1.3 Global Pomalidomide Capsules Sales Market Share by Type (2019-2030)
4.2 Global Pomalidomide Capsules Revenue by Type (2019-2030)
4.2.1 Global Pomalidomide Capsules Revenue by Type (2019-2024)
4.2.2 Global Pomalidomide Capsules Revenue by Type (2025-2030)
4.2.3 Global Pomalidomide Capsules Revenue Market Share by Type (2019-2030)
4.3 Global Pomalidomide Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pomalidomide Capsules Sales by Application (2019-2030)
5.1.1 Global Pomalidomide Capsules Sales by Application (2019-2024)
5.1.2 Global Pomalidomide Capsules Sales by Application (2025-2030)
5.1.3 Global Pomalidomide Capsules Sales Market Share by Application (2019-2030)
5.2 Global Pomalidomide Capsules Revenue by Application (2019-2030)
5.2.1 Global Pomalidomide Capsules Revenue by Application (2019-2024)
5.2.2 Global Pomalidomide Capsules Revenue by Application (2025-2030)
5.2.3 Global Pomalidomide Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Pomalidomide Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb Pomalidomide Capsules Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Chia Tai Tianqing Pharmaceutical
6.2.1 Chia Tai Tianqing Pharmaceutical Company Information
6.2.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.2.3 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product Portfolio
6.2.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.3 Qilu Pharmaceutical
6.3.1 Qilu Pharmaceutical Company Information
6.3.2 Qilu Pharmaceutical Description and Business Overview
6.3.3 Qilu Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Qilu Pharmaceutical Pomalidomide Capsules Product Portfolio
6.3.5 Qilu Pharmaceutical Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Pomalidomide Capsules Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Dr Reddy’s Laboratories
6.5.1 Dr Reddy’s Laboratories Company Information
6.5.2 Dr Reddy’s Laboratories Description and Business Overview
6.5.3 Dr Reddy’s Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dr Reddy’s Laboratories Pomalidomide Capsules Product Portfolio
6.5.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.6 Natco Pharma
6.6.1 Natco Pharma Company Information
6.6.2 Natco Pharma Description and Business Overview
6.6.3 Natco Pharma Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Natco Pharma Pomalidomide Capsules Product Portfolio
6.6.5 Natco Pharma Recent Developments/Updates
6.7 Adalvo
6.7.1 Adalvo Company Information
6.7.2 Adalvo Description and Business Overview
6.7.3 Adalvo Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Adalvo Pomalidomide Capsules Product Portfolio
6.7.5 Adalvo Recent Developments/Updates
6.8 Hetero
6.8.1 Hetero Company Information
6.8.2 Hetero Description and Business Overview
6.8.3 Hetero Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hetero Pomalidomide Capsules Product Portfolio
6.8.5 Hetero Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Company Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abbott Laboratories Pomalidomide Capsules Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pomalidomide Capsules Industry Chain Analysis
7.2 Pomalidomide Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pomalidomide Capsules Production Mode & Process
7.4 Pomalidomide Capsules Sales and Marketing
7.4.1 Pomalidomide Capsules Sales Channels
7.4.2 Pomalidomide Capsules Distributors
7.5 Pomalidomide Capsules Customers
8 Pomalidomide Capsules Market Dynamics
8.1 Pomalidomide Capsules Industry Trends
8.2 Pomalidomide Capsules Market Drivers
8.3 Pomalidomide Capsules Market Challenges
8.4 Pomalidomide Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pomalidomide Capsules Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Pomalidomide Capsules Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pomalidomide Capsules Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pomalidomide Capsules Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pomalidomide Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pomalidomide Capsules Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pomalidomide Capsules Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pomalidomide Capsules, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pomalidomide Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pomalidomide Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Pomalidomide Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pomalidomide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pomalidomide Capsules as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pomalidomide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pomalidomide Capsules Sales by Region (2019-2024) & (K Units)
Table 18. Global Pomalidomide Capsules Sales Market Share by Region (2019-2024)
Table 19. Global Pomalidomide Capsules Sales by Region (2025-2030) & (K Units)
Table 20. Global Pomalidomide Capsules Sales Market Share by Region (2025-2030)
Table 21. Global Pomalidomide Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pomalidomide Capsules Revenue Market Share by Region (2019-2024)
Table 23. Global Pomalidomide Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pomalidomide Capsules Revenue Market Share by Region (2025-2030)
Table 25. North America Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)
Table 27. North America Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)
Table 28. North America Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pomalidomide Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pomalidomide Capsules Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pomalidomide Capsules Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pomalidomide Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pomalidomide Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pomalidomide Capsules Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pomalidomide Capsules Sales (K Units) by Type (2019-2024)
Table 51. Global Pomalidomide Capsules Sales (K Units) by Type (2025-2030)
Table 52. Global Pomalidomide Capsules Sales Market Share by Type (2019-2024)
Table 53. Global Pomalidomide Capsules Sales Market Share by Type (2025-2030)
Table 54. Global Pomalidomide Capsules Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pomalidomide Capsules Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pomalidomide Capsules Revenue Market Share by Type (2019-2024)
Table 57. Global Pomalidomide Capsules Revenue Market Share by Type (2025-2030)
Table 58. Global Pomalidomide Capsules Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pomalidomide Capsules Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pomalidomide Capsules Sales (K Units) by Application (2019-2024)
Table 61. Global Pomalidomide Capsules Sales (K Units) by Application (2025-2030)
Table 62. Global Pomalidomide Capsules Sales Market Share by Application (2019-2024)
Table 63. Global Pomalidomide Capsules Sales Market Share by Application (2025-2030)
Table 64. Global Pomalidomide Capsules Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pomalidomide Capsules Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pomalidomide Capsules Revenue Market Share by Application (2019-2024)
Table 67. Global Pomalidomide Capsules Revenue Market Share by Application (2025-2030)
Table 68. Global Pomalidomide Capsules Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pomalidomide Capsules Price (US$/Unit) by Application (2025-2030)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bristol Myers Squibb Pomalidomide Capsules Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Chia Tai Tianqing Pharmaceutical Company Information
Table 76. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 77. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product
Table 79. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 80. Qilu Pharmaceutical Company Information
Table 81. Qilu Pharmaceutical Description and Business Overview
Table 82. Qilu Pharmaceutical Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Qilu Pharmaceutical Pomalidomide Capsules Product
Table 84. Qilu Pharmaceutical Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Apotex Pomalidomide Capsules Product
Table 89. Apotex Recent Developments/Updates
Table 90. Dr Reddy’s Laboratories Company Information
Table 91. Dr Reddy’s Laboratories Description and Business Overview
Table 92. Dr Reddy’s Laboratories Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Dr Reddy’s Laboratories Pomalidomide Capsules Product
Table 94. Dr Reddy’s Laboratories Recent Developments/Updates
Table 95. Natco Pharma Company Information
Table 96. Natco Pharma Description and Business Overview
Table 97. Natco Pharma Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Natco Pharma Pomalidomide Capsules Product
Table 99. Natco Pharma Recent Developments/Updates
Table 100. Adalvo Company Information
Table 101. Adalvo Description and Business Overview
Table 102. Adalvo Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Adalvo Pomalidomide Capsules Product
Table 104. Adalvo Recent Developments/Updates
Table 105. Hetero Company Information
Table 106. Hetero Description and Business Overview
Table 107. Hetero Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hetero Pomalidomide Capsules Product
Table 109. Hetero Recent Developments/Updates
Table 110. Abbott Laboratories Company Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Abbott Laboratories Pomalidomide Capsules Product
Table 114. Abbott Laboratories Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Pomalidomide Capsules Distributors List
Table 118. Pomalidomide Capsules Customers List
Table 119. Pomalidomide Capsules Market Trends
Table 120. Pomalidomide Capsules Market Drivers
Table 121. Pomalidomide Capsules Market Challenges
Table 122. Pomalidomide Capsules Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pomalidomide Capsules
Figure 2. Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pomalidomide Capsules Market Share by Type: 2023 & 2030
Figure 4. 1mg per Unit Product Picture
Figure 5. 2mg per Unit Product Picture
Figure 6. 3mg per Unit Product Picture
Figure 7. 4mg per Unit Product Picture
Figure 8. Global Pomalidomide Capsules Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Pomalidomide Capsules Market Share by Application: 2023 & 2030
Figure 10. Kaposi Sarcoma
Figure 11. Multiple Myeloma
Figure 12. Global Pomalidomide Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pomalidomide Capsules Market Size (2019-2030) & (US$ Million)
Figure 14. Global Pomalidomide Capsules Sales (2019-2030) & (K Units)
Figure 15. Global Pomalidomide Capsules Average Price (US$/Unit) & (2019-2030)
Figure 16. Pomalidomide Capsules Report Years Considered
Figure 17. Pomalidomide Capsules Sales Share by Manufacturers in 2023
Figure 18. Global Pomalidomide Capsules Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Pomalidomide Capsules Players: Market Share by Revenue in Pomalidomide Capsules in 2023
Figure 20. Pomalidomide Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Pomalidomide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Pomalidomide Capsules Sales Market Share by Country (2019-2030)
Figure 23. North America Pomalidomide Capsules Revenue Market Share by Country (2019-2030)
Figure 24. United States Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Pomalidomide Capsules Sales Market Share by Country (2019-2030)
Figure 27. Europe Pomalidomide Capsules Revenue Market Share by Country (2019-2030)
Figure 28. Germany Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Pomalidomide Capsules Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Pomalidomide Capsules Revenue Market Share by Region (2019-2030)
Figure 35. China Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Pomalidomide Capsules Sales Market Share by Country (2019-2030)
Figure 43. Mexico Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Pomalidomide Capsules Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Pomalidomide Capsules Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Pomalidomide Capsules by Type (2019-2030)
Figure 53. Global Revenue Market Share of Pomalidomide Capsules by Type (2019-2030)
Figure 54. Global Pomalidomide Capsules Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Pomalidomide Capsules by Application (2019-2030)
Figure 56. Global Revenue Market Share of Pomalidomide Capsules by Application (2019-2030)
Figure 57. Global Pomalidomide Capsules Price (US$/Unit) by Application (2019-2030)
Figure 58. Pomalidomide Capsules Value Chain
Figure 59. Pomalidomide Capsules Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pomalidomide Capsules Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Pomalidomide Capsules Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pomalidomide Capsules Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pomalidomide Capsules Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pomalidomide Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pomalidomide Capsules Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pomalidomide Capsules Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pomalidomide Capsules, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pomalidomide Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pomalidomide Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Pomalidomide Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pomalidomide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pomalidomide Capsules as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pomalidomide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pomalidomide Capsules Sales by Region (2019-2024) & (K Units)
Table 18. Global Pomalidomide Capsules Sales Market Share by Region (2019-2024)
Table 19. Global Pomalidomide Capsules Sales by Region (2025-2030) & (K Units)
Table 20. Global Pomalidomide Capsules Sales Market Share by Region (2025-2030)
Table 21. Global Pomalidomide Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pomalidomide Capsules Revenue Market Share by Region (2019-2024)
Table 23. Global Pomalidomide Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pomalidomide Capsules Revenue Market Share by Region (2025-2030)
Table 25. North America Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)
Table 27. North America Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)
Table 28. North America Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pomalidomide Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pomalidomide Capsules Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pomalidomide Capsules Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pomalidomide Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pomalidomide Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pomalidomide Capsules Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pomalidomide Capsules Sales (K Units) by Type (2019-2024)
Table 51. Global Pomalidomide Capsules Sales (K Units) by Type (2025-2030)
Table 52. Global Pomalidomide Capsules Sales Market Share by Type (2019-2024)
Table 53. Global Pomalidomide Capsules Sales Market Share by Type (2025-2030)
Table 54. Global Pomalidomide Capsules Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pomalidomide Capsules Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pomalidomide Capsules Revenue Market Share by Type (2019-2024)
Table 57. Global Pomalidomide Capsules Revenue Market Share by Type (2025-2030)
Table 58. Global Pomalidomide Capsules Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pomalidomide Capsules Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pomalidomide Capsules Sales (K Units) by Application (2019-2024)
Table 61. Global Pomalidomide Capsules Sales (K Units) by Application (2025-2030)
Table 62. Global Pomalidomide Capsules Sales Market Share by Application (2019-2024)
Table 63. Global Pomalidomide Capsules Sales Market Share by Application (2025-2030)
Table 64. Global Pomalidomide Capsules Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pomalidomide Capsules Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pomalidomide Capsules Revenue Market Share by Application (2019-2024)
Table 67. Global Pomalidomide Capsules Revenue Market Share by Application (2025-2030)
Table 68. Global Pomalidomide Capsules Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pomalidomide Capsules Price (US$/Unit) by Application (2025-2030)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bristol Myers Squibb Pomalidomide Capsules Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Chia Tai Tianqing Pharmaceutical Company Information
Table 76. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 77. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product
Table 79. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 80. Qilu Pharmaceutical Company Information
Table 81. Qilu Pharmaceutical Description and Business Overview
Table 82. Qilu Pharmaceutical Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Qilu Pharmaceutical Pomalidomide Capsules Product
Table 84. Qilu Pharmaceutical Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Apotex Pomalidomide Capsules Product
Table 89. Apotex Recent Developments/Updates
Table 90. Dr Reddy’s Laboratories Company Information
Table 91. Dr Reddy’s Laboratories Description and Business Overview
Table 92. Dr Reddy’s Laboratories Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Dr Reddy’s Laboratories Pomalidomide Capsules Product
Table 94. Dr Reddy’s Laboratories Recent Developments/Updates
Table 95. Natco Pharma Company Information
Table 96. Natco Pharma Description and Business Overview
Table 97. Natco Pharma Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Natco Pharma Pomalidomide Capsules Product
Table 99. Natco Pharma Recent Developments/Updates
Table 100. Adalvo Company Information
Table 101. Adalvo Description and Business Overview
Table 102. Adalvo Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Adalvo Pomalidomide Capsules Product
Table 104. Adalvo Recent Developments/Updates
Table 105. Hetero Company Information
Table 106. Hetero Description and Business Overview
Table 107. Hetero Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hetero Pomalidomide Capsules Product
Table 109. Hetero Recent Developments/Updates
Table 110. Abbott Laboratories Company Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Abbott Laboratories Pomalidomide Capsules Product
Table 114. Abbott Laboratories Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Pomalidomide Capsules Distributors List
Table 118. Pomalidomide Capsules Customers List
Table 119. Pomalidomide Capsules Market Trends
Table 120. Pomalidomide Capsules Market Drivers
Table 121. Pomalidomide Capsules Market Challenges
Table 122. Pomalidomide Capsules Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pomalidomide Capsules
Figure 2. Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pomalidomide Capsules Market Share by Type: 2023 & 2030
Figure 4. 1mg per Unit Product Picture
Figure 5. 2mg per Unit Product Picture
Figure 6. 3mg per Unit Product Picture
Figure 7. 4mg per Unit Product Picture
Figure 8. Global Pomalidomide Capsules Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Pomalidomide Capsules Market Share by Application: 2023 & 2030
Figure 10. Kaposi Sarcoma
Figure 11. Multiple Myeloma
Figure 12. Global Pomalidomide Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pomalidomide Capsules Market Size (2019-2030) & (US$ Million)
Figure 14. Global Pomalidomide Capsules Sales (2019-2030) & (K Units)
Figure 15. Global Pomalidomide Capsules Average Price (US$/Unit) & (2019-2030)
Figure 16. Pomalidomide Capsules Report Years Considered
Figure 17. Pomalidomide Capsules Sales Share by Manufacturers in 2023
Figure 18. Global Pomalidomide Capsules Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Pomalidomide Capsules Players: Market Share by Revenue in Pomalidomide Capsules in 2023
Figure 20. Pomalidomide Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Pomalidomide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Pomalidomide Capsules Sales Market Share by Country (2019-2030)
Figure 23. North America Pomalidomide Capsules Revenue Market Share by Country (2019-2030)
Figure 24. United States Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Pomalidomide Capsules Sales Market Share by Country (2019-2030)
Figure 27. Europe Pomalidomide Capsules Revenue Market Share by Country (2019-2030)
Figure 28. Germany Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Pomalidomide Capsules Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Pomalidomide Capsules Revenue Market Share by Region (2019-2030)
Figure 35. China Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Pomalidomide Capsules Sales Market Share by Country (2019-2030)
Figure 43. Mexico Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Pomalidomide Capsules Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Pomalidomide Capsules Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Pomalidomide Capsules by Type (2019-2030)
Figure 53. Global Revenue Market Share of Pomalidomide Capsules by Type (2019-2030)
Figure 54. Global Pomalidomide Capsules Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Pomalidomide Capsules by Application (2019-2030)
Figure 56. Global Revenue Market Share of Pomalidomide Capsules by Application (2019-2030)
Figure 57. Global Pomalidomide Capsules Price (US$/Unit) by Application (2019-2030)
Figure 58. Pomalidomide Capsules Value Chain
Figure 59. Pomalidomide Capsules Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232